Exenatide · source year

Exenatide research records in 2026

38 selected, source-linked Exenatide records carrying a 2026 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

38 selected records.

Evidence types

3 represented types.

Cited sources

38 distinct public records.

Explore 2026 by evidence type

3 types

Cited chronology

Exenatide records dated 2026

Open in the filterable feed →

September 2026

1 record

Literature metadata

Development of Chondroitin Sulfate ‑ Stabilized PLGA Microspheres of Exenatide via Polarity Gradient Extraction.

PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-08 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

August 2026

3 records

Regulatory

Federal Register notice 2026-16998

The Federal Register published notice 2026-16998, attributed to FDA and its parent HHS department, on 2026-08-20. Its official title is “Advisory Committee; Endocrinologic and Metabolic Drugs Advisory Committee; Renewal,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

Literature metadata

PubMed record PMID 30974038

PeptideScanner retained PubMed bibliographic metadata for PMID 30974038 at 2026-08-10T10:49:06.835Z. PubMed recorded a metadata revision date of 2026-08-08 and an Entrez history date of 2019-04-12. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

July 2026

5 records

Literature metadata

PubMed record PMID 41364402

PeptideScanner retained PubMed bibliographic metadata for PMID 41364402 at 2026-08-10T18:13:38.016Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2025-12-09. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 42171611

PeptideScanner retained PubMed bibliographic metadata for PMID 42171611 at 2026-08-10T18:13:50.652Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-05-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 42290292

PeptideScanner retained PubMed bibliographic metadata for PMID 42290292 at 2026-08-10T18:13:52.268Z. PubMed recorded a metadata revision date of 2026-07-26 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 41865922

PeptideScanner retained PubMed bibliographic metadata for PMID 41865922 at 2026-08-10T18:13:44.869Z. PubMed recorded a metadata revision date of 2026-07-13 and an Entrez history date of 2026-03-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 41597428

PeptideScanner retained PubMed bibliographic metadata for PMID 41597428 at 2026-07-30T16:11:44.888Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

June 2026

5 records

Literature metadata

PubMed record PMID 39919773

PeptideScanner retained PubMed bibliographic metadata for PMID 39919773 at 2026-07-30T16:14:10.828Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-02-07. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 42330995

PeptideScanner retained PubMed bibliographic metadata for PMID 42330995 at 2026-07-30T16:14:19.343Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 40246242

PeptideScanner retained PubMed bibliographic metadata for PMID 40246242 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 39805462

PeptideScanner retained PubMed bibliographic metadata for PMID 39805462 at 2026-07-30T16:14:08.923Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2025-01-13. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

May 2026

3 records

Literature metadata

PubMed record PMID 42175654

PeptideScanner retained PubMed bibliographic metadata for PMID 42175654 at 2026-07-30T16:20:45.825Z. PubMed recorded a metadata revision date of 2026-05-30 and an Entrez history date of 2026-05-23. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

Literature metadata

PubMed record PMID 42217255

PeptideScanner retained PubMed bibliographic metadata for PMID 42217255 at 2026-07-30T16:20:46.631Z. PubMed recorded a metadata revision date of 2026-05-30 and an Entrez history date of 2026-05-30. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

April 2026

1 record

March 2026

1 record

Regulatory

Federal Register notice 2026-04546

The Federal Register published notice 2026-04546, attributed to FDA and its parent HHS department, on 2026-03-09. Its official title is “Aspen Global Inc. c/o Lachman Consultant Services, Inc., et al.; Withdrawal of Approval of 46 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

January 2026

19 records

Literature metadata

The use of exenatide in severely burned pediatric patients.

PubMed lists PMID 20701787 in Critical care (London, England) as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., with publication-date metadata of 2010-08-11 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes.

PubMed lists PMID 12808878 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2003-04 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Summaries for patients. Exenatide therapy for type 2 diabetes.

PubMed lists PMID 17404346 in Annals of internal medicine as Journal Article, Patient Education Handout, with publication-date metadata of 2007-04-03 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents.

PubMed lists PMID 17595353 in Diabetes care as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-26 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.

PubMed lists PMID 17705687 in Diabetes technology & therapeutics as Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-08 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.

PubMed lists PMID 17872344 in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists as Journal Article, with publication-date metadata of 2007-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exenatide: new drug. Type 2 diabetes for some overweight patients.

PubMed lists PMID 18087791 in Prescrire international as Journal Article, with publication-date metadata of 2007-12 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exenatide and pancreatitis: an update.

PubMed lists PMID 18983211 in Expert opinion on drug safety as Editorial, with publication-date metadata of 2008-11 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exenatide for type 2 diabetes.

PubMed lists PMID 19135608 in Lancet (London, England) as Letter, Comment, with publication-date metadata of 2009-01-10 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy.

PubMed lists PMID 19219409 in Advances in therapy as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-02-14 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.

PubMed lists PMID 19695400 in Clinical therapeutics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.

PubMed lists PMID 19758357 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-09-16 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Clinical experience with exenatide in a routine secondary care diabetes clinic.

PubMed lists PMID 20022310 in Primary care diabetes as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Exenatide versus glibenclamide in patients with diabetes.

PubMed lists PMID 20151774 in Diabetes technology & therapeutics as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2010-03 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

[The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters].

PubMed lists PMID 20184107 in Vnitrni lekarstvi as Clinical Trial, Journal Article, with publication-date metadata of 2010-01 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

[Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].

PubMed lists PMID 20425675 in Deutsche medizinische Wochenschrift (1946) as Case Reports, Journal Article, with publication-date metadata of 2010-04-27 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus.

PubMed lists PMID 22644981 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Case Reports, Journal Article, with publication-date metadata of 2012-06-15 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

Literature metadata

Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens.

PubMed lists PMID 23039898 in The American journal of managed care as Comparative Study, Journal Article, with publication-date metadata of 2012-09 (month precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗